While initially introduced as a treatment for type-2 diabetes, patients taking glucagon-like peptide 1 (GLP-1) receptor agonists (see Text Box 1) found a discrete change in the amount and types of food they desire, including the curbing of cravings for certain less nutritious categories of foods (e.g., sweets, fried foods), which helped patients who were overweight or obese lose clinically significant amounts of weight and, with continued use, to maintain weights 15%20% lower than premedication levels (Rubino et al., 2021, Aronne et al., 2024)
Chronic Psychological Stress Accelerates Vascular Senescence and Impairs Ischemia-Induced Neovascularization: The Role of Dipeptidyl Peptidase-4/Glucagon-Like Peptide-1-Adiponectin Axis
2a and b)
Roche said Vabysmo showed a high uptake among both newly diagnosed patients as well as patients transitioning from other treatment options
(1998) confirmed this selectivity in rats, pigs, and dogs, showing Ipamorelin doses producing maximal GH release caused negligible cortisol or ACTH elevation
"This is an incredible program, especially for patients with Medicare, but there's a large population who doesn't have Medicare, perhaps doesn't have insurance, and so cost is an issue," she said